Corporate Europe Observatory

Agrifood 05-02-2020

‘New GMOs’: Kyriakides gets off on wrong foot with biased consultation

The new EU Health Commissioner Stella Kyriakides recently told EURACTIV.com that her “priority is to gather more information” on gene editing. To this end, she said, "we will be preparing a study on new genomic techniques, foreseen for spring 2021”. Clearly, the design and set-up of such a study will be crucial to its outcome, writes Nina Holland.
Economic governance 02-02-2018

EU lobbying rules must apply at the ECB

The European Central Bank should meet the same demands as the Commission when it comes to lobbyists in its advisory structure, insists the Corporate Europe Observatory.
Climate change 02-11-2017

Gas lobby keeps Europe hooked on fossil fuels

As the COP23 UN climate talks open in Bonn, the European Commission and EU member states are embarking on a massive spending spree to subsidise new gas infrastructure that will make it impossible to achieve the global warming targets agreed two years ago in Paris, writes Pascoe Sabido.
Public Affairs 14-11-2016

Lessons from the Barroso affair: How to reform Commission ethics

After months of procrastinating, Jean-Claude Juncker has now suggested extending the cooling off period for former Commission presidents. Unfortunately, the proposal is too weak to prevent scandals like ‘Barrosogate’ from happening again.
Trade & Society 18-01-2016

TTIP’s regulatory cooperation has already begun attacking democracy

The origins of EU-US proposals for "regulatory cooperation" show a process dominated by big business right from the start. The ongoing TTIP talks are seeking to enshrine and fortify a dangerous precedent, argue Kenneth Haar and Max Bank.
Climate change 07-12-2015

A heady climate for Brussels’ revolving door policy

As negotiations at the climate talks in Paris move into their second week, the revolving door in Brussels continues to spin energetically, writes Vicky Cann.
Health 07-09-2015

EU needs compulsory transparency register to rein in Big Pharma lobbying

Big Pharma is out-gunning its civil society and non-profit rivals in terms of lobbying, access, and influence at the EU institutions, write David Lundy and Rachel Tansey.
Climate change 30-04-2015

Another dirty energy dominated COP?

Privileged accesse to politicians enjoyed by big business should not be tolerated, writes Pascoe Sabido. François Hollande and his government should lead by example, refusing any interaction with dirty industries.
Public Affairs 12-03-2015

A penny for your thoughts: MEPs and the revolving door

Losing your seat in the elections can be a devastating blow for an MEP, but there can be a silver lining, especially if you were a member of a prominent parliamentary committee, writes Vicky Cann.
Vicky Cann, Corporate Europe Observatory
Public Affairs 21-01-2015

Old Commissioners, new revolving doors

Only three months after the Barroso II Commission left office, some prominent members have already made moves in their professional careers which are putting to test the EU executive’s policy on revolving doors, writes Vicky Cann.

Want to know what's going on in the EU Capitals daily? Subscribe now to our new 9am newsletter.